Enhancing green pharmacy through a quintuple helix approach in Malaysia

This academic article evaluates the operational frameworks, structural barriers, and strategic milestones required to transition Malaysia’s pharmaceutical sector into an environmentally sustainable "Green Pharmacy" ecosystem. The pharmaceutical lifecycle—ranging from high-emission chemical synthesis to the systemic micro-contamination of aquatic environments via improper active pharmaceutical ingredient (API) disposal—poses an immediate ecological and public health threat. To address these multi-faceted challenges, this study utilizes the Quintuple Helix Innovation Model to analyze how multi-sectoral collaborations can drive green chemistry practices, eco-pharmacovigilance, and sustainable drug delivery. The structural dynamics of this transition are evaluated across five integrated institutional axes: (1) Academia, spearheading molecular research in biocatalysis and designing green pharmacy curricula; (2) Industry, optimizing supply chains through biodegradable packaging and carbon-neutral manufacturing; (3) Government, enacting strict eco-labeling policies, updated waste management frameworks, and green procurement incentives; (4) Public/Civil Society, promoting community-led "eco-directed" medicine disposal and consumer demand for green-certified therapeutics; and (5) Natural Environment, serving as the core baseline that dictates environmental carrying capacity boundaries and drives resource-preservation metrics. The systemic analysis indicates that while Malaysia possesses advanced public health infrastructure, a lack of unified regulatory mandates for API environmental risk assessments limits progress. Ultimately, this research provides an applied socio-economic framework and macro-policy blueprint for environmental scientists, healthcare executives, and policymakers aiming to achieve national green technology goals.